Schedule III (US Controlled Substances Act)
GPTKB entity
Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Controlled substance schedule
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:criteria |
currently accepted medical use in treatment in the United States
abuse may lead to moderate or low physical dependence or high psychological dependence potential for abuse less than Schedule I and II |
| gptkbp:enforcedBy |
gptkb:Drug_Enforcement_Administration
|
| gptkbp:example |
gptkb:Tylenol_with_codeine
gptkb:AndroGel gptkb:Suboxone |
| https://www.w3.org/2000/01/rdf-schema#label |
Schedule III (US Controlled Substances Act)
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:partOf |
gptkb:US_Controlled_Substances_Act
|
| gptkbp:regulates |
gptkb:anabolic_steroids
gptkb:dronabinol gptkb:ketamine gptkb:buprenorphine testosterone barbiturates (certain types) |
| gptkbp:scheduleNumber |
III
|
| gptkbp:bfsParent |
gptkb:Schedule_IV_(US_Controlled_Substances_Act)
|
| gptkbp:bfsLayer |
7
|